Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ATTR-01Phase 21 trial
Accession Therapeutics Limited · Solid Tumor, Adult
- ATV-1601Phase 21 trial
Atavistik Bio, Inc · Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
- ATX-01Phase 21 trial
ARTHEx Biotech S.L. · Myotonic Dystrophy 1
- ATX-295Phase 21 trial
Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer
- ATX-898Phase 21 trial
Antares Therapeutics, Inc · Advanced Solid Tumors
- ATX101Phase 21 trial
Allay Therapeutics, Inc. · Total Knee Arthroplasty (Postoperative Pain)
- AU-007Phase 21 trial
Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma
- AUP1602-CPhase 21 trial
Aurealis Oy · Diabetic Foot Ulcer
- AV-001Phase 21 trial
Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia
- AV078Phase 21 trial
Aeovian Pharmaceuticals, Inc. · Tuberous Sclerosis Complex, Epilepsy
- AVD-104Phase 21 trial
Aviceda Therapeutics, Inc. · Geographic Atrophy of the Macula, Macular Degeneration
- AVM0703Supra-Pharmacologic Dexamethasone PhosphatePhase 21 trial
AVM Biotechnology Inc · Lymphoid Malignancies
- AVZO-023Phase 21 trial
Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
- AVZO-103Phase 21 trial
Avenzo Therapeutics, Inc. · Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors
- AVZO-1418Phase 21 trial
Avenzo Therapeutics, Inc. · Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors
- AZD0305Phase 21 trial
AstraZeneca · Multiple Myeloma
- AZD0516Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD0754Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD1163Phase 21 trial
AstraZeneca · Rheumatoid Arthritis
- AZD2693Phase 21 trial
AstraZeneca · Nonalcoholic Steatohepatitis
- AZD2811Phase 21 trial
AstraZeneca · Small-Cell Lung Cancer
- AZD3427Phase 21 trial
AstraZeneca · Pulmonary Hypertension (World Health Organization Group 2), Heart Failure
- AZD3632Phase 21 trial
AstraZeneca · Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Higher-risk Myelodysplastic Syndromes
- AZD4045Phase 21 trial
AstraZeneca · Relapsed or Refractory Multiple Myeloma
- AZD4117Phase 21 trial
AstraZeneca · Influenza A
- AZD4144Phase 21 trial
AstraZeneca · Sepsis, Acute Kidney Injury
- AZD4360Phase 21 trial
AstraZeneca · Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer
- AZD4512Phase 21 trial
AstraZeneca · B-cell Non-Hodgkin Lymphoma
- AZD4635Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung
- AZD4956Phase 21 trial
AstraZeneca · Solid Tumours
- AZD5148Phase 21 trial
AstraZeneca · Clostridioides Difficile Infection
- AZD5315Phase 21 trial
AstraZeneca · Influenza A
- AZD5462Phase 21 trial
AstraZeneca · Chronic Heart Failure
- AZD5492Phase 21 trial
AstraZeneca · B-cell Malignancies
- AZD5851Cell TherapyPhase 21 trial
AstraZeneca · Hepatocellular Carcinoma
- AZD5863Phase 21 trial
AstraZeneca · Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma
- AZD6489Phase 21 trial
AstraZeneca · RSV Respiratory Syncytial Virus
- AZD6621Phase 21 trial
AstraZeneca · Prostate Cancer
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- AZD6793Phase 21 trial
AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD)
- AZD7760Phase 21 trial
AstraZeneca · Staphylococcus Aureus
- AZD7789Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer
- AZD8205Phase 21 trial
AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer
- AZD8359Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD8421Phase 21 trial
AstraZeneca · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)
- AZD8630Phase 21 trial
AstraZeneca · Asthma
- AZD8965Phase 21 trial
AstraZeneca · Idiopathic Pulmonary Fibrosis (IPF)
- AZD9750Phase 21 trial
AstraZeneca · Prostate Cancer
- AZD9793Phase 21 trial
AstraZeneca · Hepatocellular Carcinoma
- AZD9829Phase 21 trial
AstraZeneca · Hematological Malignancies
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.